SCHI 📈 Schwab 5-10 Year Corporate - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US8085246986 • Corporate Bond

SCHI: Corporate, Bonds, Debt, Securities

The Schwab 5-10 Year Corporate Bond ETF, listed on NYSE ARCA under the ticker SCHI, is designed to track the performance of a specific index that focuses on U.S. investment-grade, taxable corporate bonds. This index includes bonds with maturities ranging from five to ten years, which helps to maintain a balanced portfolio with a moderate term to maturity. Furthermore, the bonds included in the index must have a substantial amount of outstanding face value, specifically $300 million or more, ensuring that the fund invests in highly liquid and reliable corporate debt securities.

In terms of its investment strategy, the fund adheres to a policy where it invests at least 90% of its net assets in securities that are components of the tracked index. This approach allows the fund to closely replicate the performance of the index, providing investors with exposure to a broad range of U.S. corporate bonds within the specified maturity range. The fund's ISIN, US8085246986, is a unique identifier that facilitates its trading and clearing processes. As an ETF, it offers the benefits of transparency, diversification, and flexibility, making it an attractive option for investors seeking to allocate a portion of their portfolio to corporate bonds with a moderate term to maturity.

Classification as a Corporate Bond ETF places the Schwab 5-10 Year Corporate Bond ETF in a category of investment products that are specifically designed to provide exposure to the corporate bond market. This category is characterized by a focus on investment-grade bonds, which are considered to have a lower risk of default compared to non-investment-grade bonds. By concentrating on bonds with maturities between five and ten years, the fund is able to offer a yield that is typically higher than that of shorter-term bonds, while also managing the interest rate risk associated with longer-term bonds. This makes the Schwab 5-10 Year Corporate Bond ETF a viable option for investors seeking to generate regular income from their investments while maintaining a moderate level of risk.

Additional Sources for SCHI ETF

SCHI ETF Overview

Market Cap in USD 7,666m
Category Corporate Bond
TER 0.03%
IPO / Inception 2019-10-09

SCHI ETF Ratings

Growth 5y 20.3%
Fundamental -
Dividend 78.0%
Rel. Strength Industry 158
Analysts -
Fair Price Momentum 21.85 USD
Fair Price DCF -

SCHI Dividends

Dividend Yield 12m 6.92%
Yield on Cost 5y 7.74%
Annual Growth 5y 42.37%
Payout Consistency 95.3%

SCHI Growth Ratios

Growth Correlation 3m -46.9%
Growth Correlation 12m 83.8%
Growth Correlation 5y 1.1%
CAGR 5y 2.26%
CAGR/Mean DD 5y 0.40
Sharpe Ratio 12m -0.13
Alpha -7.77
Beta 0.30
Volatility 5.98%
Current Volume 743.8k
Average Volume 20d 1326.9k
What is the price of SCHI stocks?
As of December 26, 2024, the stock is trading at USD 22.07 with a total of 743,779 shares traded.
Over the past week, the price has changed by +0.03%, over one month by -1.08%, over three months by -2.78% and over the past year by +4.31%.
Is Schwab 5-10 Year Corporate a good stock to buy?
Neither. Based on ValueRay Analyses, Schwab 5-10 Year Corporate is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.31 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SCHI as of December 2024 is 21.85. This means that SCHI is currently overvalued and has a potential downside of -1%.
Is SCHI a buy, sell or hold?
Schwab 5-10 Year Corporate has no consensus analysts rating.
What are the forecast for SCHI stock price target?
According to ValueRays Forecast Model, SCHI Schwab 5-10 Year Corporate will be worth about 23.8 in December 2025. The stock is currently trading at 22.07. This means that the stock has a potential upside of +7.66%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 23.8 7.7%